Friday, 2nd June 2023
<To guardian.ng
Search

AfDB announces $10bn war chest to fight COVID-19

The African Development Bank Group has announced the creation of the COVID-19 Response Facility to assist regional member countries fight the pandemic. The facility provides up to $10 billion to governments and the private sector. Khaled Sherif, Vice President for Regional Development, Integration and Business Delivery at the African Development Bank joins CNBC Africa for more.

Related

29 May 2022
Since North Korea reported its first official coronavirus case last week, the WHO has warned it might spread rapidly in the unvaccinated country. Ruler Kim Jong Un wants the military to turn the tide.
18 May 2022
Japan's GDP fell at an annualised rate of 1 percent in the first three months of this year as the Omicron variant of the coronavirus hampered consumer spending. Rising commodity prices also weighed on businesses in the world's third-largest economy. Plus, as unemployment remains stable in France at 7.3 percent, a steelworks factory in the northern city of Dunkirk is offering a cash bonus to employees to encourage them to recruit family members.
18 Jun 2022
US authorities determined COVID-19 vaccines should be given to children under 5, the only age group that is still ineligible for the jabs in the country.
22 Jun 2022
A new deal paves the way for the development of the first African-owned Covid-19 vaccines. Cape Town-based Afrigen is working with a Belgian biotech company to develop mRNA shots. Also, Kenya has no reproductive health legislation but the public is going to give its input on a regional bill that could make a big difference to sexual health services. Finally, in football news, Senegal's Sadio Mané moves to Bayern Munich.
23 Jun 2022
A new deal paves the way for the development of the first African-owned Covid-19 vaccines. Cape Town-based Afrigen is working with a Belgian biotech company to develop mRNA shots. Also, Kenya has no reproductive health legislation but the public is going to give its input on a regional bill that could make a big difference to sexual health services. Finally, in football news, Senegal's Sadio Mané is moving from Liverpool to Bayern Munich.
3 Jul 2022
The two pathogens that cause monkeypox and COVID-19 have a few things in common, but there are also many differences – especially when it comes to ease of transmission.
16 Jul 2022
The COVID-19 variant Omicron BA.5 has the ability to reinfect people within weeks of contracting the virus, experts have warned. BA.5 is currently outpacing other variants in infection and is the dominant strain in the US and abroad. "What we are seeing is an increasing number of people who have been infected with BA.2 and then becoming infected after four weeks," Andrew Roberston, Chief Health Officer In Western Australia.
18 Jul 2022
German hospitals are struggling as beds fill up and nursing staff falls ill with COVID. Even freshly trained health care workers complain about unsustainable levels of stress and worsening conditions.
22 Jul 2022
United States of America's President, Joe Biden has tested positive for COVID-19. White House press secretary, Karine Jean-Pierre, disclosed in a statement, noting that the 79-year-old president is experiencing “very mild symptoms.” Biden is fully vaccinated with the Pfizer-BioNTech COVID-19 vaccine
29 Aug 2022
German leaders are debating how to deal with a potential increase in coronavirus infections once the colder months begin. But COVID plans are controversial. DW's Thomas Sparrow has the details.
14 Sep 2022
The World Health Organization (WHO) found that roughly 10% to 20% of Europeans who recovered from COVID-19 suffered from long-term health effects such as fatigue, breathlessness and cognitive dysfunction.
20 Sep 2022
US President Joe Biden's claim in a TV interview that "the pandemic is over" has triggered a sell-off, wiping over $10 billion off the market value of the main Covid-19 vaccine makers. Investors are worried about public apathy towards Covid and the resulting impact on demand for vaccines and boosters.